These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 27893031)

  • 1. The β-HPV Subtypes-Cornerstone of the Next-Generation Vaccine.
    Chahoud J; Rieber AG; Tyring SK
    JAMA Oncol; 2017 May; 3(5):594-595. PubMed ID: 27893031
    [No Abstract]   [Full Text] [Related]  

  • 2. Health economic analysis of human papillomavirus vaccines in women of Chile: perspective of the health care payer using a Markov model.
    Gomez JA; Lepetic A; Demarteau N
    BMC Public Health; 2014 Nov; 14():1222. PubMed ID: 25424716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylaxis of cervical cancer and related cervical disease: a review of the cost-effectiveness of vaccination against oncogenic HPV types.
    Armstrong EP
    J Manag Care Pharm; 2010 Apr; 16(3):217-30. PubMed ID: 20331326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prevention of cervical cancer by HPV vaccine].
    Konno R
    Gan To Kagaku Ryoho; 2010 Feb; 37(2):236-9. PubMed ID: 20235395
    [No Abstract]   [Full Text] [Related]  

  • 5. Developments in L2-based human papillomavirus (HPV) vaccines.
    Schellenbacher C; Roden RBS; Kirnbauer R
    Virus Res; 2017 Mar; 231():166-175. PubMed ID: 27889616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness analysis of the introduction of the human papillomavirus vaccine in Honduras.
    Aguilar IB; Mendoza LO; García O; Díaz I; Figueroa J; Duarte RM; Perdomo G; Garcia AG; Janusz CB
    Vaccine; 2015 May; 33 Suppl 1():A167-73. PubMed ID: 25919157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Developments in HPV vaccination].
    de Melker H; Kenter G; van Rossum T; Conyn-van Spaendonck M
    Ned Tijdschr Geneeskd; 2012; 156(47):A5410. PubMed ID: 23171565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HPV vaccination in Italy: perspectives after 1-year experience.
    Icardi G
    J Prev Med Hyg; 2008 Dec; 49(4):125-8. PubMed ID: 19350958
    [No Abstract]   [Full Text] [Related]  

  • 9. The economic impact of HPV vaccines: not just cervical cancer.
    Myers ER
    Am J Obstet Gynecol; 2008 May; 198(5):487-8. PubMed ID: 18455522
    [No Abstract]   [Full Text] [Related]  

  • 10. Knowledge of cervical cancer and the HPV vaccine.
    Paniagua H
    Br J Nurs; 2006 Feb 9-22; 15(3):126-7. PubMed ID: 16493315
    [No Abstract]   [Full Text] [Related]  

  • 11. HPV vaccine facts: can't see the forest through the trees.
    Bryan J
    Hum Vaccin; 2007; 3(6):295-6. PubMed ID: 17622802
    [No Abstract]   [Full Text] [Related]  

  • 12. No Vacillation on HPV Vaccination.
    Sipp D; Frazer IH; Rasko JEJ
    Cell; 2018 Mar; 172(6):1163-1167. PubMed ID: 29522737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention strategies of cervical cancer in the HPV vaccine era.
    Bosch X; Harper D
    Gynecol Oncol; 2006 Oct; 103(1):21-4. PubMed ID: 16919714
    [No Abstract]   [Full Text] [Related]  

  • 14. Human papillomavirus vaccines and vaccine implementation.
    de Sanjosé S; Alemany L; Castellsagué X; Bosch FX
    Womens Health (Lond); 2008 Nov; 4(6):595-604. PubMed ID: 19072462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survey hints at uneven adoption of cancer vaccine.
    Boughton B
    Nat Med; 2008 Jan; 14(1):5. PubMed ID: 18180705
    [No Abstract]   [Full Text] [Related]  

  • 16. A prophylactic quadrivalent vaccine for the prevention of infection and disease related to HPV-6, -11, -16 and -18.
    Goldstone SE; Vuocolo S
    Expert Rev Vaccines; 2012 Apr; 11(4):395-406. PubMed ID: 22551023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HPV vaccine protects at multiple sites, even for some previously exposed.
    Printz C
    Cancer; 2015 Sep; 121(17):2863. PubMed ID: 26291437
    [No Abstract]   [Full Text] [Related]  

  • 18. [AN HPV-ASSOCIATED DISEASES AND CERVICAL CANCER AND PROPHYLACTIC HUMAN PAPILLOMAVIRUS (HPV) VACCINES].
    Malinova M
    Akush Ginekol (Sofiia); 2015; 54 Suppl 1():25-31. PubMed ID: 26137767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human papillomavirus vaccination: where to now?
    Garland SM
    Sex Transm Infect; 2011 Dec; 87 Suppl 2(Suppl 2):ii23-4. PubMed ID: 22110148
    [No Abstract]   [Full Text] [Related]  

  • 20. [BENEFITS AND RISKS AT IMPLEMENTATION OF PROPHILACTIC VACCINES FOR CERVICAL CANCER].
    Zlatkov V; Kostova P
    Akush Ginekol (Sofiia); 2016; 55(3):28-33. PubMed ID: 27514142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.